[Federal Register Volume 69, Number 191 (Monday, October 4, 2004)]
[Notices]
[Page 59267]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 04-22157]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production act of 1993--American Society for Blood and Marrow 
Transplantation

    Notice is hereby given that, on September 10, 2004, pursuant to 
section 6(a) of the National Cooperative Research and Production act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), American Society for Blood 
and Marrow Transplantation (``ASBMT'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the name and principal place of business of 
the standards development organization and (2) the nature and scope of 
its standards development activities. The notifications were filed for 
the purpose of invoking the Act's provisions limiting the recovery of 
antitrust plaintiffs to actual damages under specified circumstances.
    Pursuant to section 6(b) of the Act, the name and principal place 
of business of the standards development organization is American 
Society for Blood and Marrow Transplantation (``ASBMT'') Arlington 
Heights, IL 60005-4460. The nature and scope of ASBMT's standards 
development activities are to develop, plan, establish, coordinate, and 
publish voluntary consensus standards applicable to the field of 
cellular therapy and blood and marrow transplantation. Specifically, 
ASBMT develops, plans, establishes coordinates, and publishes voluntary 
consensus standards in the form of: Policy statements relating to the 
effectiveness of transplant therapies; transplant center guidelines; 
physician training guidelines; and clinical practice guidelines in the 
form of evidence-based reviews. Through its standard development 
activities, ASBMT seeks to ensure the highest quality of medical 
practice, define commonly accepted medical practice, and develop 
standards of medical care as related to the field of cellular therapy 
and blood and marrow transplantation. ASBMT's standards development 
activities are ongoing in nature, and existing guidelines and policy 
statements may be updated and/or amended from time to time.

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 04-22157 Filed 10-1-04; 8:45 am]
BILLING CODE 4410-11-M